Presentation

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V in Real-World Patients: TWENTE

Presenter: C. Von Birgelen

February 20, 2012

REGISTER for free or LOG IN to view this content

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V in Real-World Patients: TWENTE

DES/BRS/DCB

Factoid

Up Next

Presentation

Primary Endpoint Results of the EVOLVE Trial

Presenter: Ian T. Meredith

February 21, 2012

More slides +

Presentation

Patient Safety and Outcomes from Live Case Demonstrations of Interventional Cardiology Procedures

Presenter: S. Eliyahu

February 21, 2012

Presentation

Resultados Punti Final Primario del Ensayo EVOLVE

Presenter: Ian T. Meredith

February 21, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.